Earnings Summary

Abbott Laboratories’s revenue jumped 4.85% since last year same period to $10635Mn in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 2.49% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit jumped 14.62% since last year same period to $1646Mn in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 26.42% jump in its net profits since last 3-months.

Abbott Laboratories’s net profit margin jumped 9.32% since last year same period to 15.48% in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 23.35% jump in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a 9.09% jump from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.2.

Abbott Laboratories’s earning per share (EPS) jumped 6.14% since last year same period to 1.21 in the Q3 2024. This indicates that the Abbott Laboratories has generated 6.14% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.55 dividend per share during the earnings announcement for Q3 2024.